Prescription Drug Abuse | Behavioral Healthcare Magazine Skip to content Skip to navigation

Prescription Drug Abuse

Medicaid coverage of MAT drugs varies

August 22, 2017  |  Julie Miller, Editor in Chief
article

All states have Medicaid plans that are covering some drugs used in medication assisted treatment, according to a draft report from SAMHSA.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Contributing Editor
article

The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

NCAD: Resources, not rhetoric, will combat the addiction crisis

August 17, 2017  |  Julie Miller, Editor in Chief
article

In the ongoing fight to combat the opioid crisis, lack of resources has become the biggest limitation to saving lives.

FACT FILE: OIG flags opioid misuse, questionable prescribing in Medicare Part D

August 10, 2017  |  Tom Valentino, Senior Editor
news

A study of Medicare Part D data from 2016 by the U.S. Department of Health and Human Services Office of Inspector General identifies cases of extreme use of opioids, questionable prescribing and doctor shopping by beneficiaries.

Missouri sets up PDMP at last—but with caveats

August 9, 2017  |  Julie Miller, Editor in Chief
article

Missouri is positioned to launch a statewide prescription drug monitoring program at last, but clinical professionals will not have access to patient-specific data to potentially prevent or treat addiction disorders.

SAMHSA research sheds light on prescription drug misuse

August 9, 2017  |  Tom Valentino, Senior Editor
article

Two recent reports issued by SAMHSA show reasons for prescription medication misuse and an increase in opioid misuse among U.S. adults over the age of 50.

Trump, HHS believe we already have what we need to address opioid crisis

August 9, 2017  |  Julie Miller, Editor in Chief
blog

The Department of Health and Human Services basically told America that Trump is not planning to follow the urgent recommendation to declare a national state of emergency for the opioid crisis.

New fraud unit targets pill mills

August 3, 2017  |  Julie Miller, Editor in Chief
news

The Department of Justice launched the Opioid Fraud and Abuse Detection Unit as a three-year pilot program, largely aimed at shutting down pill mills and drug diversion in 12 hard-hit states.

White House Commission misses recovery support

August 1, 2017  |  Julie Miller, Editor in Chief
article

The first report produced by a federal commission asks the president to declare a national state of emergency for the opioid crisis, while at the same time, it misses one obvious solution.

Largest takedown in history halts opioid diversion, brokering, kickbacks

July 14, 2017  |  Julie Miller, Editor in Chief
article

On Thursday, federal officials announced a massive enforcement action that involved charging 412 people, including some from addiction treatment centers.

Drug courts aim to broaden their scope

July 12, 2017  |  Julie Miller, Editor in Chief
article

There are about 3,000 drug courts in the United States, and as the number increases, experts say the models must become broader in scope as well as more nuanced in interactions with program participants.

Drug maker agrees to stop selling Opana ER because of misuse

July 6, 2017  |  Julie Miller, Editor in Chief
news

Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, about a month after FDA requested that the company stop selling the product because of the growing incidents of misuse.

Pages

Subscribe to Prescription Drug Abuse